Dosed multiple Rett syndrome patients in REVEAL pivotal trial of TSHA-102, with enrollment advancing across multiple sites; on track to complete dosing in Q2 2026 Received FDA clearance to initiate AS ...
Joining me on today’s call are Sean Nolan, Taysha Gene Therapies, Inc.'s Chief Executive Officer; Sukumar Nagendran, ...
President Donald Trump faces the most daunting question of the Iran war: Will he put U.S. troops on the ground to secure the enriched uranium Tehran could use to build nuclear weapons?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results